Patent US4034101A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4034101A Expired / Lapsed US ⏱️ 0.0 years remaining

N-Oxy and N-amino guanidines

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1975-06-11
•
Granted: 1977-07-05
•
Expires: 1995-06-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds are N-oxy and N-amino guanidines which are histamine H2-antagonists. A compound of this invention is N-hydroxy-N'methyl-N''-[2-((4-methyl-5-imidazolyl)methylthio)-ethyl]gu anidine.

Inventors

  • 👤 Graham John Durant
  • 👤 Charon Robin Ganellin
  • 👤 Geoffrey Robert Owen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 16:47
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/64; A; A61; A61P; A61P43/00; C07C; C07C281/00; C07C281/16; C07C281/18; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/32; C07D277/00; C07D277/02; C07D277/20; C07D277/22; C07D277/26; C07D277/28

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 124 words
A compound of the formula: ##STR5## wherein R 1 represents a grouping of the structure shown in the formula: Het-- (CH.sub.2).sub.m Z(CH.sub.2).sub.n FORMULA II wherein Het is imidazole which is attached at a ring carbon and which is optionally substituted by lower alkyl, chlorine or bromine; Z is sulphur or a methylene group; m is 0, 1 or 2 and n is 2 or 3 provided that the sum of m and n is 3 or 4; R 2 is hydrogen, lower alkyl or a grouping of the structure shown in Formula II wherein Het, m, n and Z are as defined above; X is oxygen and R 3 is hydrogen, lower alkyl, phenyl or benzyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 124 words
A compound of the formula: ##STR5## wherein R 1 represents a grouping of the structure shown in the formula: Het-- (CH.sub.2).sub.m Z(CH.sub.2).sub.n FORMULA II wherein Het is imidazole which is attached at a ring carbon and which is optionally substituted by lower alkyl, chlorine or bromine; Z is sulphur or a methylene group; m is 0, 1 or 2 and n is 2 or 3 provided that the sum of m and n is 3 or 4; R 2 is hydrogen, lower alkyl or a grouping of the structure shown in Formula II wherein Het, m, n and Z are as defined above; X is oxygen and R 3 is hydrogen, lower alkyl, phenyl or benzyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 10 words
A compound of claim 1 wherein R 3 is hydrogen.
Claim 4
Dependent Claim 11 words
A compound of claim 1 wherein R 2 is lower alkyl.
Claim 5
Dependent Claim 15 words
A compound of claim 1 wherein R 2 is the same as R 1 .
Claim 6
Dependent Claim 13 words
A compound of claim 1 wherein m is 1 and n is 2.
Claim 7
Dependent Claim 9 words
A compound of claim 1 wherein Z is sulphur.
Claim 8
Dependent Claim 26 words
A compound of claim 1 wherein Het is imidazole which is attached at a ring carbon and which is optionally substituted by methyl, chlorine or bromine.
Claim 9
Dependent Claim 9 words
A compound of claim 1, said compound being N-hydroxy-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine.
Claim 10
Dependent Claim 10 words
A compound of claim 1, said compound being N-hydroxy-N', N"-bis[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine.
Claim 11
Dependent Claim 9 words
A compound of claim 1, said compound being N-methoxy-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine.
Claim 12
Dependent Claim 10 words
A compound of claim 1, said compound being N-methoxy-N', N"-bis[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine.
Claim 13
Dependent Claim 32 words
A pharmaceutical composition to block histamine H 2 -receptors comprising a pharmaceutically acceptable diluent or carrier and, in an effective amount to block histamine H 2 -receptors, a compound of claim 1.
Claim 14
Dependent Claim 38 words
A method of blocking histamine H 2 -receptors which comprises administering to an animal in need of blocking of histamine H 2 -receptors in an effective amount to block histamine H 2 -receptors a compound of claim 1.
Claim 15
Dependent Claim 30 words
A method of inhibiting gastric acid secretion which comprises administering to an animal in need thereof in an effective amount to inhibit gastric acid secretion a compound of claim 1.
Claim 16
Dependent Claim 50 words
A compound of the formula: ##STR6## wherein Het is imidazole which is attached at a ring carbon and which is optionally substituted by lower alkyl, chlorine or bromine; X is oxygen or NH; and R is hydrogen, lower alkyl, phenyl or benzyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 17
Dependent Claim 50 words
A compound of the formula: ##STR6## wherein Het is imidazole which is attached at a ring carbon and which is optionally substituted by lower alkyl, chlorine or bromine; X is oxygen or NH; and R is hydrogen, lower alkyl, phenyl or benzyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 18
Dependent Claim 10 words
A compound of claim 15, said compound being N-amino-N',N" -bis[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine.
Claim 19
Dependent Claim 32 words
A pharmaceutical composition to block histamine H 2 -receptors comprising a pharmaceutically acceptable diluent or carrier and, in an effective amount to block histamine H 2 -receptors, a compound of claim 15.
Claim 20
Dependent Claim 38 words
A method of blocking histamine H 2 -receptors which comprises administering to an animal in need of blocking of histamine H 2 -receptors in an effective amount to block histamine H 2 -receptors a compound of claim 15.
Claim 21
Dependent Claim 30 words
A method of inhibiting gastric acid secretion which comprises administering to an animal in need thereof in an effective amount to inhibit gastric acid secretion a compound of claim 15.

References Cited (Backward Citations)

DE2053175A1 Cited
DE2211454A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-04 1981-01-03 1981-07-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-04 1985-01-03 1985-07-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-04 1989-01-03 1989-07-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag